Recombinant human erythropoietin (rhEPO) treatment potentiates growth hormone (GH) response to growth hormone releasing hormone (GHRH) stimulation in hemodialysis patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples